|Day Low/High||34.03 / 34.96|
|52 Wk Low/High||0.00 / 0.00|
OPKO Health, Inc. (NYSE:OPK) and Bio-Reference Laboratories, Inc.
The most recent short interest data has been released by the NASDAQ for the 06/15/2015 settlement date, which shows a 459,969 share decrease in total short interest for Bio-Reference Laboratories, Inc. , to 4,008,998, a decrease of 10.29% since 05/29/2015.
Answering viewers' Twitter questions, Jim Cramer warned investors off Sears and Delta, praised GE, and discussed whether Nike or Under Armour will gain more from the NBA Finals.
Jim Cramer answers viewers' Twitter (TWTR) questions from the floor of the New York Stock Exchange.
Trade-Ideas LLC identified Bio-Reference Laboratories (BRLI) as a "perilous reversal" (up big yesterday but down big today) candidate
Bio-Reference Labs (BRLI) shares are rising after the company agreed to be acquired by Opko Health (OPK) for $1.47 billion.
Merger With OPKO Health, Inc. to Create a Bold New Future for the Company
Along with the networking company's results, we start to get retail earnings.
Cramer will be watching earnings from Sears, Lululemon and Cisco, among others, next week.
Markets had a lot to digest on Thursday from a global bond rout to an unexpected extension to Greece's debt repayments to a meeting among the world's largest oil producers.
Stocks plumb new lows by mid-afternoon Thursday as the IMF agrees to allow Greece to repay its debt later this month.
TheStreet highlights 3 stocks pushing the health services industry higher today.
The following statement is being issued by Levi & Korsinsky, LLP: To: All Persons or Entities who purchased Bio-Reference stock prior to June 4, 2015 .
Dish Network (DISH) spiked on reports the company is discussing a potential merger with T-Mobile (TMUS).
Selling covered calls and naked puts can reduce risk. (Updated)
Bio-Reference Laboratories (BRLI) stock is rallying after the company was bought by OPKO Health (OPK) for around $1.47 billion.
Stocks fall to session lows after briefly flirting with positive territory Thursday morning.
Shareholder rights law firm Johnson & Weaver, LLP has launched an investigation into whether the board members of Bio-Reference Laboratories, Inc.
Stock futures are lower on Thursday as uncertainty over a Greek debt deal and anticipation ahead of a meeting of the Organization of the Petroleum Exporting Countries pressured markets.
OPKO HEALTH, INC. (NYSE:OPK) and Bio-Reference Laboratories, Inc.
Trade-Ideas LLC identified Bio-Reference Laboratories (BRLI) as a weak on high relative volume candidate
Improvement in Cash Flow and Increase in Revenue Per Patient, 3 Cents/Share Related to Increase in Legal Expenses
NextGen Sequencing Expert Leads Company Initiative With Custom, Cost Effective Panels in Both Solid Tumors and Hematologic Cancers
The New Business Group Will be the Commercial Collaborations and Innovations Group
The Company's Fourth Quarter Financial Results Showed Substantial Year Over Year Improvement